Literature DB >> 34046699

Wicking microfluidic approach to separate blood plasma from whole blood to facilitate downstream assays.

Gayan C Bandara1, Linus J Unitan1, Matthew H Kremer2, Owen T Shellhammer1, Shay Bracha3,4, Vincent T Remcho5,6.   

Abstract

Separation of blood plasma or serum from blood is essential for accurate analysis. Conventional blood separation requires instrumentation, reagents, and large sample volumes, limiting this process to laboratory environments with trained personnel. Full implementation of effective blood separation and analysis on microliter sample volumes for point of care (POC) diagnostics has proven extremely challenging resulting in a growing market demand, with common challenges such as expensive device fabrication processes or devices being comprised of materials which are not easily disposable. We developed a membrane-based wicking microfluidic device which is made using a simple fabrication process. This device uses a unique 3D flow channel geometry, fabricated in a polycaprolactone-filled glass microfiber membrane, to efficiently separate microliter sample volumes of blood. Colorimetric assay chemistries were integrated to demonstrate utility of these devices in POC diagnostics. The devices are capable of separating both fresh and anticoagulant-treated blood at microscale sample volumes (<15.0 μL). Modifications to the base device are also reported herein which increased sample volume capacity and separation efficiency. Integrated colorimetric assay enabled semi-quantitative detection of conjugated bilirubin in real blood samples (1.0-1.5 mg/dL). These blood separation devices, fabricated on polycaprolactone-filled glass microfiber, enabled effective blood plasma (anticoagulant-treated blood) and serum (fresh blood) separation with microscale sample volumes. Sample volume capacity and separation efficiency are customizable for specific applications and devices can be integrated with downstream assay chemistries to develop complete POC devices that offer blood separation and diagnostics at the same time on a single membrane.

Entities:  

Keywords:  Blood separation; Glass microfiber; Plasma; Point of care diagnostics; Polycaprolactone; Serum

Year:  2021        PMID: 34046699     DOI: 10.1007/s00216-021-03420-6

Source DB:  PubMed          Journal:  Anal Bioanal Chem        ISSN: 1618-2642            Impact factor:   4.142


  28 in total

1.  Large-volume centrifugal microfluidic device for blood plasma separation.

Authors:  Mary Amasia; Marc Madou
Journal:  Bioanalysis       Date:  2010-10       Impact factor: 2.681

2.  Dengue NS1 detection in pediatric serum using microfluidic paper-based analytical devices.

Authors:  Muhammad Hatta Prabowo; Supawat Chatchen; Patsamon Rijiravanich; Kriengsak Limkittikul; Werasak Surareungchai
Journal:  Anal Bioanal Chem       Date:  2020-03-12       Impact factor: 4.142

3.  DNA fragments in the blood plasma of cancer patients: quantitations and evidence for their origin from apoptotic and necrotic cells.

Authors:  S Jahr; H Hentze; S Englisch; D Hardt; F O Fackelmayer; R D Hesch; R Knippers
Journal:  Cancer Res       Date:  2001-02-15       Impact factor: 12.701

Review 4.  Detection of circulating tumour DNA in the blood (plasma/serum) of cancer patients.

Authors:  P Anker; H Mulcahy; X Q Chen; M Stroun
Journal:  Cancer Metastasis Rev       Date:  1999       Impact factor: 9.264

5.  Utility of a rapid B-natriuretic peptide assay in differentiating congestive heart failure from lung disease in patients presenting with dyspnea.

Authors:  L Katherine Morrison; Alex Harrison; Padma Krishnaswamy; Radmila Kazanegra; Paul Clopton; Alan Maisel
Journal:  J Am Coll Cardiol       Date:  2002-01-16       Impact factor: 24.094

6.  Microvolume blood-sampling device with low hemolysis and high consistent yield of serum components.

Authors:  Y Tanaka; Y Noda; M Kobayashi; Y Yamada; K Hirao
Journal:  Clin Chem       Date:  2001-10       Impact factor: 8.327

7.  Utility of B-type natriuretic peptide in the diagnosis of congestive heart failure in an urgent-care setting.

Authors:  Q Dao; P Krishnaswamy; R Kazanegra; A Harrison; R Amirnovin; L Lenert; P Clopton; J Alberto; P Hlavin; A S Maisel
Journal:  J Am Coll Cardiol       Date:  2001-02       Impact factor: 24.094

Review 8.  American Cancer Society guidelines for the early detection of cancer, 2006.

Authors:  Robert A Smith; Vilma Cokkinides; Harmon J Eyre
Journal:  CA Cancer J Clin       Date:  2006 Jan-Feb       Impact factor: 508.702

9.  Circulating microRNAs as stable blood-based markers for cancer detection.

Authors:  Patrick S Mitchell; Rachael K Parkin; Evan M Kroh; Brian R Fritz; Stacia K Wyman; Era L Pogosova-Agadjanyan; Amelia Peterson; Jennifer Noteboom; Kathy C O'Briant; April Allen; Daniel W Lin; Nicole Urban; Charles W Drescher; Beatrice S Knudsen; Derek L Stirewalt; Robert Gentleman; Robert L Vessella; Peter S Nelson; Daniel B Martin; Muneesh Tewari
Journal:  Proc Natl Acad Sci U S A       Date:  2008-07-28       Impact factor: 11.205

Review 10.  HbA(1c) as a screening tool for detection of Type 2 diabetes: a systematic review.

Authors:  C M Bennett; M Guo; S C Dharmage
Journal:  Diabet Med       Date:  2007-03-15       Impact factor: 4.359

View more
  1 in total

Review 1.  Current Advancements and Future Road Map to Develop ASSURED Microfluidic Biosensors for Infectious and Non-Infectious Diseases.

Authors:  Tanu Bhardwaj; Lakshmi Narashimhan Ramana; Tarun Kumar Sharma
Journal:  Biosensors (Basel)       Date:  2022-05-20
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.